Morel C, Parise L, Van der Zee Y, Issler O, Cai M, Browne C
Sci Rep. 2024; 14(1):30785.
PMID: 39730457
PMC: 11680947.
DOI: 10.1038/s41598-024-80767-7.
Stauch K, Black T, Abramson C
Insects. 2024; 15(7).
PMID: 39057227
PMC: 11277305.
DOI: 10.3390/insects15070494.
Reclaw R, Lachowicz M, Chmielowiec K, Chmielowiec J, Stronska-Pluta A, Kowalski M
Int J Mol Sci. 2024; 25(1).
PMID: 38203701
PMC: 10779366.
DOI: 10.3390/ijms25010532.
Chmielowiec K, Chmielowiec J, Masiak J, Stronska-Pluta A, Lachowicz M, Boron A
Int J Mol Sci. 2023; 24(6).
PMID: 36982343
PMC: 10049030.
DOI: 10.3390/ijms24065265.
Graham D, Harding M, Nielsen D
Methods Mol Biol. 2022; 2547:437-490.
PMID: 36068473
DOI: 10.1007/978-1-0716-2573-6_16.
Methylation in the Promoter Region of the Dopamine Transporter Gene in People Addicted to Nicotine.
Chmielowiec J, Chmielowiec K, Stronska-Pluta A, Suchanecka A, Huminska-Lisowska K, Lachowicz M
Int J Environ Res Public Health. 2022; 19(14).
PMID: 35886451
PMC: 9321476.
DOI: 10.3390/ijerph19148602.
Opioid Addiction and Opioid Receptor Dimerization: Structural Modeling of the OPRD1 and OPRM1 Heterodimer and Its Signaling Pathways.
Wu B, Hand W, Alexov E
Int J Mol Sci. 2021; 22(19).
PMID: 34638633
PMC: 8509015.
DOI: 10.3390/ijms221910290.
The Gut Microbiome and Substance Use Disorder.
Russell J, Zhou Y, Weinstock G, Bubier J
Front Neurosci. 2021; 15:725500.
PMID: 34531718
PMC: 8439419.
DOI: 10.3389/fnins.2021.725500.
Understanding the genetics and neurobiological pathways behind addiction (Review).
Popescu A, Marian M, Dragoi A, Costea R
Exp Ther Med. 2021; 21(5):544.
PMID: 33815617
PMC: 8014976.
DOI: 10.3892/etm.2021.9976.
Parental drinking according to parental composition and adolescent binge drinking: findings from a nationwide high school survey in Japan.
Inoura S, Shimane T, Kitagaki K, Wada K, Matsumoto T
BMC Public Health. 2020; 20(1):1878.
PMID: 33287791
PMC: 7720457.
DOI: 10.1186/s12889-020-09969-8.
Genetic Vulnerability to Opioid Addiction.
Reed B, Kreek M
Cold Spring Harb Perspect Med. 2020; 11(6).
PMID: 32205416
PMC: 8168526.
DOI: 10.1101/cshperspect.a039735.
Substance Use Disorder, Intravenous Injection, and HIV Infection: A Review.
Wang S, Maher B
Cell Transplant. 2019; 28(12):1465-1471.
PMID: 31547679
PMC: 6923556.
DOI: 10.1177/0963689719878380.
Opioid Addiction, Genetic Susceptibility, and Medical Treatments: A Review.
Wang S, Chen Y, Lee C, Cheng C
Int J Mol Sci. 2019; 20(17).
PMID: 31480739
PMC: 6747085.
DOI: 10.3390/ijms20174294.
Genetic, Psychological, and Personal Network Factors Associated With Changes in Binge Drinking Over 2 Years Among Mexican Heritage Adolescents in the USA.
Song S, Marcum C, Wilkinson A, Shete S, Koehly L
Ann Behav Med. 2018; 53(2):126-137.
PMID: 29697747
PMC: 6200652.
DOI: 10.1093/abm/kay019.
Alcohol effects on the epigenome in the germline: Role in the inheritance of alcohol-related pathology.
Chastain L, Sarkar D
Alcohol. 2017; 60:53-66.
PMID: 28431793
PMC: 5515627.
DOI: 10.1016/j.alcohol.2016.12.007.
Genetic polymorphisms in genes related to risk-taking behaviours predicting body mass index trajectory among Mexican American adolescents.
Zhao H, Wilkinson A, Shen J, Wu X, Chow W
Pediatr Obes. 2016; 12(5):356-362.
PMID: 27228958
PMC: 5319917.
DOI: 10.1111/ijpo.12151.
Demographic, psychosocial, and genetic risk associated with smokeless tobacco use among Mexican heritage youth.
Wilkinson A, Koehly L, Vandewater E, Yu R, Fisher-Hoch S, Prokhorov A
BMC Med Genet. 2015; 16:43.
PMID: 26111525
PMC: 4636823.
DOI: 10.1186/s12881-015-0188-8.
Family-based interventions for the prevention of substance abuse and other impulse control disorders in girls.
Kumpfer K
ISRN Addict. 2015; 2014:308789.
PMID: 25938121
PMC: 4392980.
DOI: 10.1155/2014/308789.
Multigenerational and transgenerational inheritance of drug exposure: The effects of alcohol, opiates, cocaine, marijuana, and nicotine.
Yohn N, Bartolomei M, Blendy J
Prog Biophys Mol Biol. 2015; 118(1-2):21-33.
PMID: 25839742
PMC: 4459901.
DOI: 10.1016/j.pbiomolbio.2015.03.002.
Impact of prospectively determined A118G polymorphism on treatment response to injectable naltrexone among methamphetamine-dependent patients: an open-label, pilot study.
Pal R, Mendelson J, Flower K, Garrison K, Yount G, Coyle J
J Addict Med. 2015; 9(2):130-5.
PMID: 25622123
PMC: 4375053.
DOI: 10.1097/ADM.0000000000000107.